Sökresultat

Parkinsons sjukdom utvecklas i takt med att hjärnans nervceller bryts ner. Nedbrytningen orsakas av skadliga ansamlingar av proteinet alfa-synuklein. Nu har forskar vid Lunds universitet i samarbete med europeiska kollegor fått en ökad förståelse för hur dessa ansamlingar, proteinaggregat, uppstår. Resultaten publiceras i Cell Reports. Hjärnan består av miljarder nervceller som för att fungera är

https://www.medicin.lu.se/artikel/nya-ron-om-astrocyternas-roll-vid-parkinson - 2025-12-11

New research supports the theory that certain viral infections are of importance in the development of type 1 diabetes. An international research team has discovered that young children with an increased genetic risk of type 1 diabetes had an increased risk of developing diabetes-related autoantibodies in connection with Covid-19 infection. Swedish children have contributed to the study which has

https://www.ludc.lu.se/article/new-study-virus-importance-development-type-1-diabetes - 2025-12-11

Lund University Diabetes Centre’s Scientific Advisory Board give researchers valuable feedback on ongoing research. Frances Ashcroft and Flemming Pociot from the board were invited to the LUDC retreat in the city of Helsingborg recently and they were impressed by the range of the research being performed at the centre. Research within type 1 diabetes specifically caught their attention. Frances As

https://www.ludc.lu.se/article/scientific-advisory-board-important-contributions-within-type-1-diabetes-research - 2025-12-11

An international consensus report on diabetes identifies the potential for diabetes screening, better classification of type 2 diabetes, and biomarkers that can predict cardiovascular disease. The report also highlights that more evidence is needed before it is possible to provide individualised treatment to all patients. The report is based on a large collaboration between 28 universities worldwi

https://www.ludc.lu.se/article/new-report-highlights-opportunities-and-challenges-precision-diabetes-medicine - 2025-12-11

How do heritability and the fetal environment affect the risk for the child to develop type 2 diabetes? This is a question that Rashmi Prasad studies in her research projects that that may lead to individualised prevention measures. She will be awarded this year’s recipient Medeon stipend on the World Diabetes Day Skåne event on November 14. Diabetes researcher Rashmi Prasad at Lund University Dia

https://www.ludc.lu.se/article/research-inherited-type-2-diabetes-awarded - 2025-12-11

Diabetes researcher and cardiologist Isabel Goncalves at Lund University Diabetes Centre (LUDC) has teamed up with ultrasound researchers at the Faculty of Engineering at Lund University (LTH) to identify dangerous atherosclerotic plaques at an early stage. The team is now being awarded Lund University’s and Sparbanken Skåne’s Future Innovations Award to develop their idea further. In atherosclero

https://www.ludc.lu.se/article/innovation-aims-identify-dangerous-atherosclerotic-plaques-wins-prize - 2025-12-11

Do epigenetic changes cause type 2 diabetes, or do the changes occur only after a person has become ill? A new study by researchers at Lund University provides increased support for the idea that epigenetic changes can cause type 2 diabetes. The researchers behind the new findings published in Nature Communications now aim to develop methods for disease prevention. We inherit our genes from our pa

https://www.ludc.lu.se/article/epigenetic-changes-can-cause-type-2-diabetes - 2025-12-11

An international team of researchers has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The analysis was led by Lund University, Johns Hopkins University, and the Chinese University of Hong Kong. The study was published in Communications Medicine. Although people with type 2 diabetes are two times mo

https://www.ludc.lu.se/article/new-study-biomarkers-improve-prediction-cardiovascular-disease-type-2-diabetes - 2025-12-11

Much research on diabetes focuses on understanding what happens when the insulin-producing cells are destroyed. Researchers at Lund University have instead chosen to investigate what protects the insulin-producing cells. Their research shows that a protein of the immune system protects the insulin-producing cells from inflammation and death. The study, published in PNAS, is an example of basic res

https://www.ludc.lu.se/article/protein-protects-insulin-producing-cells - 2025-12-11

Diabetes researchers Allan Vaag and Lena Eliasson are the new coordinators of Lund University Diabetes Centre (LUDC) and the strategic research area EXODIAB (Excellence of Diabetes Research in Sweden). Over the next years, they will work to strengthen and further develop ongoing collaborations. Coordinator Allan Vaag and Vice Coordinator Lena Eliasson are new leaders since the beginning of the yea

https://www.ludc.lu.se/article/new-coordinators-strategic-research-area-diabetes - 2025-12-11

Do you think that people with obesity have themselves to blame? Tune H Pers tries to dispel persistent myths through his research on the brain's role in the development of obesity. The diabetes researcher at the University of Copenhagen is now awarded the Leif C. Groop award for his research on obesity and type 2 diabetes. Justification for awarding"Tune H Pers receives the Leif C. Groop Award for

https://www.ludc.lu.se/article/tune-h-pers-receives-award-outstanding-research-obesity-and-diabetes - 2025-12-11

A treatment that has reduced plaque development in mice has now been tested in people with psoriasis. Jan Nilsson at Lund University is one of the researchers behind the clinical study that showed a reduced inflammation of the coronary arteries, which in turn may reduce the risk of dying from a heart attack. People with diabetes may also benefit from the treatment in the future. Cardiovascular res

https://www.ludc.lu.se/article/new-treatment-atherosclerosis-may-reduce-risk-dying-heart-attack - 2025-12-11

Why are some people with obesity protected from type 2 diabetes? Who is at risk of developing gestational diabetes and type 2 diabetes? The Hjelt Diabetes Foundation awards two diabetes researchers at Lund University Diabetes Centre grants for projects that are seeking new answers to these questions. Gestational diabetes happens when the body cannot produce enough insulin during pregnancy. The con

https://www.ludc.lu.se/article/research-obesity-and-gestational-diabetes-receive-support-hjelt-diabetes-foundation - 2025-12-11

People with a hereditary risk of obesity lose as much weight as a result of better diet, exercise and weight loss drugs as the rest of the population, according to an international study presented in The BMJ. “This indicates that even in people at genetic risk of obesity, lifestyle change is an effective way to lose weight”, says Professor Paul Franks of Lund University in Sweden, one of the resea

https://www.ludc.lu.se/article/no-link-between-obesity-gene-and-intentional-weight-loss - 2025-12-11

Interest in type 1 diabetes screening is growing as methods improve and new treatments become available to more patients. New research at Lund University demonstrates how screening for autoimmune diseases can be carried out on a large-scale basis. A new treatment that can delay the onset of type 1 diabetes has been approved for use in the United States. If the treatment Teplizumab becomes availabl

https://www.ludc.lu.se/article/new-method-allows-large-scale-screening-autoimmune-diseases - 2025-12-11

The EAT-Lancet diet is a framework designed to promote environmental sustainability while also preventing common diseases such as type 2 diabetes. How do we know if the diet actually works? An international research team studied seven dietary scores and found that two of them were particularly good at evaluating adherence to the diet. Reliable diet scores are important when developing sustainable

https://www.ludc.lu.se/article/research-paves-way-sustainable-dietary-recommendations - 2025-12-11

The dream of finding the “diabetes gene” is dead. However, partly thanks to Leif Groop – professor and multiple award recipient for his ground-breaking research – we will look at type 2 diabetes in a whole new way in the future. He is now retiring, and in an interview with diabetesportalen.se he looks back on his eventful career in research. The study that since 2006 has been the central hub of th

https://www.ludc.lu.se/article/time-burie-lada-interview-leif-groop - 2025-12-11

Researchers at Lund University in Sweden have discovered that the appetite hormone CART is regulated by glucose and is found in greater quantity in people with type 2 diabetes. “This could be the body’s own defence mechanism to lower blood sugar levels in case of type 2 diabetes”, says Associate Professor Nils Wierup, in charge of the study. The study shows that the appetite hormone CART not only

https://www.ludc.lu.se/article/antidiabetic-effects-discovered-appetite-hormone-cart - 2025-12-11

Heart attack and stroke are common complications of diabetes, as the body's ability to repair and form vessels is impaired. Researchers at Lund University have developed a new substance with the capacity to stimulate vascular repair response and the formation of vessels. In diabetes, the body's ability to repair vascular damage caused by the disease is impaired, which can lead to complications suc

https://www.ludc.lu.se/article/new-peptide-may-reduce-risk-diabetes-complications - 2025-12-11

Precision medicine seeks to reduce errors and improve accuracy in medical and health recommendations, but better evidence is needed to fulfil its potential. An international consortium led by Paul Franks at Lund University presents new guidelines that may increase the clinical relevance of precision medicine research. An international consensus report on precision medicine that was published in Na

https://www.ludc.lu.se/article/new-guidelines-aim-increase-accuracy-precision-medicine-research - 2025-12-11